Symptomatic acute pancreatitis induced by nilotinib in a patient with chronic myeloid leukaemia

Med Clin (Barc). 2024 Jan 26;162(2):91-92. doi: 10.1016/j.medcli.2023.08.008. Epub 2023 Oct 12.

[Article in English, Spanish]

Authors

Khadija Mansour¹, Nesrine Ben Sayed², Bouraoui Ouni³

Affiliations

¹ Department of Pharmacology, Faculty of Medicine of Sousse, Sousse, Tunisia. Electronic address: khadija.mansour2@gmail.com.
² Department of Clinical Hematology, Farhat Hached University Hospital, Sousse, Tunisia.
³ Department of Pharmacology, Faculty of Medicine of Sousse, Sousse, Tunisia.

PMID: 37838535
DOI: 10.1016/j.medcli.2023.08.008

No abstract available

Publication types

Letter

MeSH terms

Acute Disease
Antineoplastic Agents* / adverse effects
Chronic Disease
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / drug therapy
Pancreatitis* / chemically induced
Pancreatitis* / diagnosis
Protein Kinase Inhibitors / adverse effects
Pyrimidines / adverse effects

Substances

Pyrimidines
Antineoplastic Agents
Protein Kinase Inhibitors